BridgeBio Oncology Therapeutics (BBOT) Price to Earnings (2024 - 2025)
BridgeBio Oncology Therapeutics' (BBOT) Price to Earnings came in at 140.44 for Q2 2025, up 80.1% from the prior quarter.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Price to Earnings (2024 - 2025) Analysis & Trends
For FY2024, BridgeBio Oncology Therapeutics' Price to Earnings stood at 29.24.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | BridgeBio Oncology Therapeutics | 315.65 Mn | -1.06 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 140.44 |
| Mar 31, 2025 | 77.96 |
| Dec 31, 2024 | 29.24 |
API Access
BridgeBio Oncology Therapeutics Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=BBOT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "BBOT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=BBOT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();